Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review Article
  • Published:

Endocrine regulation of ageing

Key Points

  • Mutations in single genes can increase the lifespans of lower metazoan organisms (worms and flies) and mammals. Many of these mutations affect genes that are involved in endocrine signalling pathways.

  • Attenuation of signalling through the insulin/insulin-like growth factor-1 (IGF1) pathways prolongs the lifespans of worms and flies. Decreased IGF1 signalling also prolongs lifespan in mammals; however, diminished insulin signalling has been shown to prolong lifespan in mammals only when limited to adipocytes.

  • The regulation of ageing by some hormone-receptor pathways is cell non-autonomous; genetic changes in a small group of cells can alter the lifespan of the whole organism. For example, worms that carry mutations in the insulin/IGF1 pathway in only a few cells are long-lived, and mice with a fat-specific insulin-receptor deficiency are also long-lived.

  • Lipophilic hormones, including steroids, also modulate ageing in worms and flies. Related lipophilic hormones are present in mammals; however, the role of lipophilic hormones in regulating mammalian ageing has not yet been defined.

  • A protein encoded by the Klotho gene can circulate in the blood and might function as a hormone. Overexpression of Klotho prolongs lifespan, possibly by altering insulin signalling.

  • The regulation of lifespan by cell non-autonomous endocrine pathways might allow exploitation of the inherent specificity of hormone–receptor interactions to alter the ageing process.

Abstract

Over the past 15 years it has become clear that mutations in genes that regulate endocrine signalling pathways can prolong lifespan. Lifespan can be increased by altered endocrine signalling in a group of cells or a single tissue, which indicates that crosstalk between tissues functions to coordinate ageing of the organism. These endocrine pathways might serve as targets for the manipulation of the ageing process and prevention of age-related diseases.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Cell non-autonomous regulation of lifespan by insulin/insulin-like growth factor-1 signalling in worms.
Figure 2: Cell non-autonomous regulation of lifespan by insulin/IGF1 signalling in flies.
Figure 3: Regulation of lifespan by insulin/IGF1 signalling in mice.
Figure 4: Regulation of lifespan by lipophilic signals in worms and flies.
Figure 5: Possible regulation of lifespan by steroid hormones in mice.

Similar content being viewed by others

References

  1. Oeppen, J. & Vaupel, J. W. Demography. Broken limits to life expectancy. Science 296, 1029–1031 (2002).

    CAS  PubMed  Google Scholar 

  2. Wilmoth, J. R., Deegan, L. J., Lundstrom, H. & Horiuchi, S. Increase of maximum life-span in Sweden, 1861–1999. Science 289, 2366–2368 (2000).

    CAS  PubMed  Google Scholar 

  3. Masoro, E. J. Overview of caloric restriction and ageing. Mech. Ageing Dev. 126, 913–922 (2005).

    CAS  PubMed  Google Scholar 

  4. Ahmet, I., Wan, R., Mattson, M. P., Lakatta, E. G. & Talan, M. Cardioprotection by intermittent fasting in rats. Circulation 112, 3115–3121 (2005).

    PubMed  Google Scholar 

  5. Hursting, S. D., Lavigne, J. A., Berrigan, D., Perkins, S. N. & Barrett, J. C. Calorie restriction, aging, and cancer prevention: mechanisms of action and applicability to humans. Annu. Rev. Med. 54, 131–152 (2003).

    CAS  PubMed  Google Scholar 

  6. Stern, J. S., Gades, M. D., Wheeldon, C. M. & Borchers, A. T. Calorie restriction in obesity: prevention of kidney disease in rodents. J. Nutr. 131, 913S–917S (2001).

    CAS  PubMed  Google Scholar 

  7. Bodkin, N. L., Alexander, T. M., Ortmeyer, H. K., Johnson, E. & Hansen, B. C. Mortality and morbidity in laboratory-maintained Rhesus monkeys and effects of long-term dietary restriction. J. Gerontol. A. Biol. Sci. Med. Sci. 58, 212–219 (2003).

    PubMed  Google Scholar 

  8. Mattson, M. P. & Wan, R. Beneficial effects of intermittent fasting and caloric restriction on the cardiovascular and cerebrovascular systems. J. Nutr. Biochem. 16, 129–137 (2005).

    CAS  PubMed  Google Scholar 

  9. Heilbronn, L. K. et al. Effect of 6-month calorie restriction on biomarkers of longevity, metabolic adaptation, and oxidative stress in overweight individuals: a randomized controlled trial. JAMA 295, 1539–1548 (2006).

    CAS  PubMed  PubMed Central  Google Scholar 

  10. Kimura, K. D., Tissenbaum, H. A., Liu, Y. & Ruvkun, G. daf-2, an insulin receptor-like gene that regulates longevity and diapause in Caenorhabditis elegans. Science 277, 942–946 (1997). Provides the first evidence for endocrine regulation of lifespan by showing that the protein encoded by daf-2 is a homologue of the mammalian IGF1 and insulin receptors.

    CAS  PubMed  Google Scholar 

  11. Kenyon, C., Chang, J., Gensch, E., Rudner, A. & Tabtiang, R. A C. elegans mutant that lives twice as long as wild type. Nature 366, 461–464 (1993). Shows that a mutation in a single gene (later found to encode a hormone receptor) could dramatically lengthen lifespan.

    CAS  PubMed  Google Scholar 

  12. Kenyon, C. The plasticity of aging: insights from long-lived mutants. Cell 120, 449–460 (2005).

    CAS  PubMed  Google Scholar 

  13. Liang, H. et al. Genetic mouse models of extended lifespan. Exp. Gerontol. 38, 1353–1364 (2003).

    CAS  PubMed  Google Scholar 

  14. Hwangbo, D. S., Gersham, B., Tu, M. P., Palmer, M. & Tatar, M. Drosophila dFOXO controls lifespan and regulates insulin signalling in brain and fat body. Nature 429, 562–566 (2004). Demonstrates that the activity of FOXO in the D. melanogaster fat body can regulate lifespan cell non-autonomously.

    CAS  PubMed  Google Scholar 

  15. Wolkow, C. A., Kimura, K. D., Lee, M. S. & Ruvkun, G. Regulation of C. elegans life-span by insulinlike signaling in the nervous system. Science 290, 147–150 (2000).

    CAS  PubMed  Google Scholar 

  16. Libina, N., Berman, J. R. & Kenyon, C. Tissue-specific activities of C. elegans DAF-16 in the regulation of lifespan. Cell 115, 489–502 (2003).

    CAS  PubMed  Google Scholar 

  17. Giannakou, M. E. et al. Long-lived Drosophila with overexpressed dFOXO in adult fat body. Science 305, 361 (2004).

    CAS  PubMed  Google Scholar 

  18. Bluher, M., Kahn, B. B. & Kahn, C. R. Extended longevity in mice lacking the insulin receptor in adipose tissue. Science 299, 572–574 (2003). Shows that insulin signalling in adipocytes can regulate lifespan cell non-autonomously in mice.

    PubMed  Google Scholar 

  19. Kuro-o M. et al. Mutation of the mouse klotho gene leads to a syndrome resembling ageing. Nature 390, 45–51 (1997).

    CAS  PubMed  Google Scholar 

  20. Kurosu, H. et al. Suppression of aging in mice by the hormone Klotho. Science 309, 1829–1833 (2005). Provides the first evidence that KLOTHO can prolong lifespan and demonstrated insulin and IGF1 resistance in Klotho -transgenic mice.

    CAS  PubMed  PubMed Central  Google Scholar 

  21. Simon, A. F., Shih, C., Mack, A. & Benzer, S. Steroid control of longevity in Drosophila melanogaster. Science 299, 1407–1410 (2003).

    CAS  PubMed  Google Scholar 

  22. Tatar, M. et al. A mutant Drosophila insulin receptor homolog that extends life-span and impairs neuroendocrine function. Science 292, 107–110 (2001). Demonstrates a role for insulin signalling in lifespan regulation in D. melanogaster.

    CAS  PubMed  Google Scholar 

  23. Mak, H. Y. & Ruvkun, G. Intercellular signaling of reproductive development by the C. elegans DAF-9 cytochrome P450. Development 131, 1777–1786 (2004).

    CAS  PubMed  Google Scholar 

  24. Hsin, H. & Kenyon, C. Signals from the reproductive system regulate the lifespan of C. elegans. Nature 399, 362–366 (1999).

    CAS  PubMed  Google Scholar 

  25. Broue, F., Liere, P., Kenyon, C. & Baulieu, E. E. A steroid hormone that extends the lifespan of Caenorhabditis elegans. Aging Cell 6, 87–94 (2007). Identifies a steroid hormone found in mammals as a regulator of lifespan in C. elegans.

    CAS  PubMed  Google Scholar 

  26. Arantes-Oliveira, N., Berman, J. R. & Kenyon, C. Healthy animals with extreme longevity. Science 302, 611 (2003).

    CAS  PubMed  Google Scholar 

  27. Hertweck, M., Gobel, C. & Baumeister, R. C. elegans SGK-1 is the critical component in the Akt/PKB kinase complex to control stress response and life span. Dev. Cell 6, 577–588 (2004).

    CAS  PubMed  Google Scholar 

  28. Ogg, S. et al. The fork head transcription factor DAF-16 transduces insulin-like metabolic and longevity signals in C. elegans. Nature 389, 994–999 (1997).

    CAS  PubMed  Google Scholar 

  29. Lin, K., Dorman, J. B., Rodan, A. & Kenyon, C. daf-16: an HNF-3/forkhead family member that can function to double the life-span of Caenorhabditis elegans. Science 278, 1319–1322 (1997).

    CAS  PubMed  Google Scholar 

  30. Henderson, S. T. & Johnson, T. E. daf-16 integrates developmental and environmental inputs to mediate aging in the nematode Caenorhabditis elegans. Curr. Biol. 11, 1975–1980 (2001).

    CAS  PubMed  Google Scholar 

  31. Lin, K., Hsin, H., Libina, N. & Kenyon, C. Regulation of the Caenorhabditis elegans longevity protein DAF-16 by insulin/IGF-1 and germline signaling. Nature Genet. 28, 139–145 (2001).

    CAS  PubMed  Google Scholar 

  32. Lee, S. S., Kennedy, S., Tolonen, A. C. & Ruvkun, G. DAF-16 target genes that control C. elegans life-span and metabolism. Science 300, 644–647 (2003).

    CAS  PubMed  Google Scholar 

  33. Oh, S. W. et al. Identification of direct DAF-16 targets controlling longevity, metabolism and diapause by chromatin immunoprecipitation. Nature Genet. 38, 251–257 (2006).

    PubMed  Google Scholar 

  34. Murphy, C. T. et al. Genes that act downstream of DAF-16 to influence the lifespan of Caenorhabditis elegans. Nature 424, 277–283 (2003).

    CAS  PubMed  Google Scholar 

  35. Apfeld, J. & Kenyon, C. Cell nonautonomy of C. elegans daf-2 function in the regulation of diapause and life span. Cell 95, 199–210 (1998). Describes for the first time that ageing can be regulated cell non-autonomously by a hormone receptor.

    CAS  PubMed  Google Scholar 

  36. Giannakou, M. E. et al. Dynamics of the action of dFOXO on adult mortality in Drosophila. Aging Cell 26 April 2007 (doi: 10.1111/j.1474-9726.2007.00290.x). Shows that overexpression of FOXO in the fat body can reduce mortality acutely.

    CAS  PubMed  Google Scholar 

  37. Brown-Borg, H. M., Borg, K. E., Meliska, C. J. & Bartke, A. Dwarf mice and the ageing process. Nature 384, 33 (1996). Demonstrates that Ames dwarf mice, which are deficient in several pituitary hormones, have increased lifespans.

    CAS  PubMed  Google Scholar 

  38. Vergara, M., Smith-Wheelock, M., Harper, J. M., Sigler, R. & Miller, R. A. Hormone-treated Snell dwarf mice regain fertility but remain long lived and disease resistant. J. Gerontol. A. Biol. Sci. Med. Sci. 59, 1244–1250 (2004).

    PubMed  Google Scholar 

  39. Flurkey, K., Papaconstantinou, J. & Harrison, D. E. The Snell dwarf mutation Pit1(dw) can increase life span in mice. Mech. Ageing Dev. 123, 121–130 (2002).

    CAS  PubMed  Google Scholar 

  40. Coschigano, K. T., Clemmons, D., Bellush, L. L. & Kopchick, J. J. Assessment of growth parameters and life span of GHR/BP gene-disrupted mice. Endocrinology 141, 2608–2613 (2000).

    CAS  PubMed  Google Scholar 

  41. Coschigano, K. T. et al. Deletion, but not antagonism, of the mouse growth hormone receptor results in severely decreased body weights, insulin, and insulin-like growth factor I levels and increased life span. Endocrinology 144, 3799–3810 (2003).

    CAS  PubMed  Google Scholar 

  42. Flurkey, K., Papaconstantinou, J., Miller, R. A. & Harrison, D. E. Lifespan extension and delayed immune and collagen aging in mutant mice with defects in growth hormone production. Proc. Natl Acad. Sci. USA 98, 6736–6741 (2001).

    CAS  PubMed  PubMed Central  Google Scholar 

  43. Eicher, E. M. & Beamer, W. G. Inherited ateliotic dwarfism in mice. Characteristics of the mutation, little, on chromosome 6. J. Hered. 67, 87–91 (1976).

    CAS  PubMed  Google Scholar 

  44. Holzenberger, M. et al. IGF-1 receptor regulates lifespan and resistance to oxidative stress in mice. Nature 421, 182–187 (2003).

    CAS  PubMed  Google Scholar 

  45. Hauck, S. J., Hunter, W. S., Danilovich, N., Kopchick, J. J. & Bartke, A. Reduced levels of thyroid hormones, insulin, and glucose, and lower body core temperature in the growth hormone receptor/binding protein knockout mouse. Exp. Biol. Med. 226, 552–558 (2001).

    CAS  Google Scholar 

  46. Holzenberger, M. et al. Experimental IGF-I receptor deficiency generates a sexually dimorphic pattern of organ-specific growth deficits in mice, affecting fat tissue in particular. Endocrinology 142, 4469–4478 (2001).

    CAS  PubMed  Google Scholar 

  47. Harper, J. M., Durkee, S. J., Dysko, R. C., Austad, S. N. & Miller, R. A. Genetic modulation of hormone levels and life span in hybrids between laboratory and wild-derived mice. J. Gerontol. A. Biol. Sci. Med. Sci. 61, 1019–1029 (2006).

    PubMed  Google Scholar 

  48. Accili, D. et al. Early neonatal death in mice homozygous for a null allele of the insulin receptor gene. Nature Genet. 12, 106–109 (1996).

    CAS  PubMed  Google Scholar 

  49. Facchini, F. S., Hua, N., Abbasi, F. & Reaven, G. M. Insulin resistance as a predictor of age-related diseases. J. Clin. Endocrinol. Metab. 86, 3574–3578 (2001).

    CAS  PubMed  Google Scholar 

  50. Biddinger, S. B. & Kahn, C. R. From mice to men: insights into the insulin resistance syndromes. Annu. Rev. Physiol. 68, 123–158 (2006).

    CAS  PubMed  Google Scholar 

  51. Bluher, M. et al. Adipose tissue selective insulin receptor knockout protects against obesity and obesity-related glucose intolerance. Dev. Cell 3, 25–38 (2002).

    CAS  PubMed  Google Scholar 

  52. Ahima, R. S. & Flier, J. S. Adipose tissue as an endocrine organ. Trends Endocrinol. Metab. 11, 327–332 (2000).

    CAS  PubMed  Google Scholar 

  53. Weiss, E. P. et al. Improvements in glucose tolerance and insulin action induced by increasing energy expenditure or decreasing energy intake: a randomized controlled trial. Am. J. Clin. Nutr. 84, 1033–1042 (2006).

    CAS  PubMed  Google Scholar 

  54. Zhu, M. et al. Circulating adiponectin levels increase in rats on caloric restriction: the potential for insulin sensitization. Exp. Gerontol. 39, 1049–1059 (2004).

    CAS  PubMed  Google Scholar 

  55. Belanger, C., Luu-The, V., Dupont, P. & Tchernof, A. Adipose tissue intracrinology: potential importance of local androgen/estrogen metabolism in the regulation of adiposity. Horm. Metab. Res. 34, 737–745 (2002).

    CAS  PubMed  Google Scholar 

  56. Moore, X. L., Hoong, I. & Cole, T. J. Expression of the 11β-hydroxysteroid dehydrogenase 2 gene in the mouse. Kidney Int. 57, 1307–1312 (2000).

    CAS  PubMed  Google Scholar 

  57. Urs, S., Harrington, A., Liaw, L. & Small, D. Selective expression of an aP2/fatty acid binding protein 4-Cre transgene in non-adipogenic tissues during embryonic development. Transgenic Res. 15, 647–653 (2006).

    CAS  PubMed  Google Scholar 

  58. Pelton, P. D., Zhou, L., Demarest, K. T. & Burris, T. P. PPARγ activation induces the expression of the adipocyte fatty acid binding protein gene in human monocytes. Biochem. Biophys. Res. Commun. 261, 456–458 (1999).

    CAS  PubMed  Google Scholar 

  59. Iida, K. T. et al. Insulin up-regulates tumor necrosis factor-α production in macrophages through an extracellular-regulated kinase-dependent pathway. J. Biol. Chem. 276, 32531–32537 (2001).

    CAS  PubMed  Google Scholar 

  60. Iida, K. T. et al. Insulin inhibits apoptosis of macrophage cell line, THP-1 cells, via phosphatidylinositol-3-kinase-dependent pathway. Arterioscler. Thromb. Vasc. Biol. 22, 380–386 (2002).

    CAS  PubMed  Google Scholar 

  61. Weisberg, S. P. et al. Obesity is associated with macrophage accumulation in adipose tissue. J. Clin. Invest. 112, 1796–1808 (2003).

    CAS  PubMed  PubMed Central  Google Scholar 

  62. Baba, T. et al. Estrogen, insulin, and dietary signals cooperatively regulate longevity signals to enhance resistance to oxidative stress in mice. J. Biol. Chem. 280, 16417–16426 (2005).

    CAS  PubMed  Google Scholar 

  63. Yamamoto, M. et al. Regulation of oxidative stress by the anti-aging hormone Klotho. J. Biol. Chem. 280, 38029–38034 (2005).

    CAS  PubMed  Google Scholar 

  64. Migliaccio, E. et al. The p66shc adaptor protein controls oxidative stress response and life span in mammals. Nature 402, 309–313 (1999).

    CAS  PubMed  Google Scholar 

  65. Wijchers, P. J., Burbach, J. P. & Smidt, M. P. In control of biology: of mice, men and Foxes. Biochem. J. 397, 233–246 (2006).

    CAS  PubMed  PubMed Central  Google Scholar 

  66. Nakae, J., Kitamura, T., Silver, D. L. & Accili, D. The forkhead transcription factor Foxo1 (Fkhr) confers insulin sensitivity onto glucose-6-phosphatase expression. J. Clin. Invest. 108, 1359–1367 (2001).

    CAS  PubMed  PubMed Central  Google Scholar 

  67. Puigserver, P. et al. Insulin-regulated hepatic gluconeogenesis through FOXO1–PGC-1α interaction. Nature 423, 550–555 (2003).

    CAS  PubMed  Google Scholar 

  68. Samuel, V. T. et al. Targeting Foxo1 in mice using antisense oligonucleotide improves hepatic and peripheral insulin action. Diabetes 55, 2042–2050 (2006).

    CAS  PubMed  Google Scholar 

  69. Nakae, J. et al. Regulation of insulin action and pancreatic β-cell function by mutated alleles of the gene encoding forkhead transcription factor Foxo1. Nature Genet. 32, 245–253 (2002).

    CAS  PubMed  Google Scholar 

  70. Nakae, J. et al. The forkhead transcription factor Foxo1 regulates adipocyte differentiation. Dev. Cell 4, 119–129 (2003).

    CAS  PubMed  Google Scholar 

  71. Puig, O. & Tjian, R. Transcriptional feedback control of insulin receptor by dFOXO/FOXO1. Genes Dev. 19, 2435–2446 (2005).

    CAS  PubMed  PubMed Central  Google Scholar 

  72. Haigis, M. C. & Guarente, L. P. Mammalian sirtuins — emerging roles in physiology, aging, and calorie restriction. Genes Dev. 20, 2913–2921 (2006).

    CAS  PubMed  Google Scholar 

  73. Longo, V. D. & Kennedy, B. K. Sirtuins in aging and age-related disease. Cell 126, 257–268 (2006).

    CAS  PubMed  Google Scholar 

  74. Berdichevsky, A., Viswanathan, M., Horvitz, H. R. & Guarente, L. C. elegans SIR-2.1 interacts with 14-3-3 proteins to activate DAF-16 and extend life span. Cell 125, 1165–1177 (2006).

    CAS  PubMed  Google Scholar 

  75. McBurney, M. W. et al. The mammalian SIR2α protein has a role in embryogenesis and gametogenesis. Mol. Cell. Biol. 23, 38–54 (2003).

    CAS  PubMed  PubMed Central  Google Scholar 

  76. Lemieux, M. E. et al. The Sirt1 deacetylase modulates the insulin-like growth factor signaling pathway in mammals. Mech. Ageing Dev. 126, 1097–1105 (2005).

    CAS  PubMed  Google Scholar 

  77. Rodgers, J. T. et al. Nutrient control of glucose homeostasis through a complex of PGC-1α and SIRT1. Nature 434, 113–118 (2005).

    CAS  PubMed  Google Scholar 

  78. Picard, F. et al. Sirt1 promotes fat mobilization in white adipocytes by repressing PPAR-γ. Nature 429, 771–776 (2004).

    CAS  PubMed  PubMed Central  Google Scholar 

  79. Jing, E., Gesta, S. & Kahn, C. R. Sirt2 regulates adipocyte differentiation involving FoxO1 acetylation/deacetylation. Cell Metab. (in the press).

  80. Moynihan, K. A. et al. Increased dosage of mammalian Sir2 in pancreatic β cells enhances glucose-stimulated insulin secretion in mice. Cell Metab. 2, 105–117 (2005).

    CAS  PubMed  Google Scholar 

  81. Bordone, L. et al. Sirt1 regulates insulin secretion by repressing UCP2 in pancreatic β cells. PLoS Biol. 4, e31 (2006).

    PubMed  Google Scholar 

  82. Wood, J. G. et al. Sirtuin activators mimic caloric restriction and delay ageing in metazoans. Nature 430, 686–689 (2004).

    CAS  PubMed  Google Scholar 

  83. Howitz, K. T. et al. Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature 425, 191–196 (2003).

    CAS  PubMed  Google Scholar 

  84. Lagouge, M. et al. Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1α. Cell 127, 1109–1122 (2006).

    CAS  PubMed  Google Scholar 

  85. Baur, J. A. et al. Resveratrol improves health and survival of mice on a high-calorie diet. Nature 444, 337–342 (2006).

    CAS  PubMed  PubMed Central  Google Scholar 

  86. Tohyama, O. et al. Klotho is a novel β-glucuronidase capable of hydrolyzing steroid β-glucuronides. J. Biol. Chem. 279, 9777–9784 (2004).

    CAS  PubMed  Google Scholar 

  87. Shiraki-Iida, T. et al. Structure of the mouse klotho gene and its two transcripts encoding membrane and secreted protein. FEBS Lett. 424, 6–10 (1998).

    CAS  PubMed  Google Scholar 

  88. Imura, A. et al. Secreted Klotho protein in sera and CSF: implication for post-translational cleavage in release of Klotho protein from cell membrane. FEBS Lett. 565, 143–147 (2004).

    CAS  PubMed  Google Scholar 

  89. Mori, K. et al. Disruption of klotho gene causes an abnormal energy homeostasis in mice. Biochem. Biophys. Res. Commun. 278, 665–670 (2000).

    CAS  PubMed  Google Scholar 

  90. Utsugi, T. et al. Decreased insulin production and increased insulin sensitivity in the klotho mutant mouse, a novel animal model for human aging. Metabolism 49, 1118–1123 (2000).

    CAS  PubMed  Google Scholar 

  91. Yoshida, T., Fujimori, T. & Nabeshima, Y. Mediation of unusually high concentrations of 1,25-dihydroxyvitamin D in homozygous klotho mutant mice by increased expression of renal 1α-hydroxylase gene. Endocrinology 143, 683–689 (2002).

    CAS  PubMed  Google Scholar 

  92. Tsujikawa, H., Kurotaki, Y., Fujimori, T., Fukuda, K. & Nabeshima, Y. Klotho, a gene related to a syndrome resembling human premature aging, functions in a negative regulatory circuit of vitamin D endocrine system. Mol. Endocrinol. 17, 2393–2403 (2003).

    CAS  PubMed  Google Scholar 

  93. Shimada, T. et al. Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism. J. Clin. Invest 113, 561–568 (2004). Shows that KLOTHO cooperates with FGF23 to bind to FGF receptors.

    CAS  PubMed  PubMed Central  Google Scholar 

  94. Kurosu, H. et al. Regulation of fibroblast growth factor-23 signaling by klotho. J. Biol. Chem. 281, 6120–6123 (2006).

    CAS  PubMed  Google Scholar 

  95. Yamashita, T., Konishi, M., Miyake, A., Inui, K. & Itoh, N. Fibroblast growth factor (FGF)-23 inhibits renal phosphate reabsorption by activation of the mitogen-activated protein kinase pathway. J. Biol. Chem. 277, 28265–28270 (2002).

    CAS  PubMed  Google Scholar 

  96. Bouzakri, K. et al. Reduced activation of phosphatidylinositol-3 kinase and increased serine 636 phosphorylation of insulin receptor substrate-1 in primary culture of skeletal muscle cells from patients with type 2 diabetes. Diabetes 52, 1319–1325 (2003).

    CAS  PubMed  Google Scholar 

  97. Yaylaoglu, M. B. et al. Comprehensive expression atlas of fibroblast growth factors and their receptors generated by a novel robotic in situ hybridization platform. Dev. Dyn. 234, 371–386 (2005).

    CAS  PubMed  Google Scholar 

  98. Chang, Q. et al. The β-glucuronidase klotho hydrolyzes and activates the TRPV5 channel. Science 310, 490–493 (2005).

    CAS  PubMed  Google Scholar 

  99. Arking, D. E. et al. Association of human aging with a functional variant of Klotho. Proc. Natl Acad. Sci. USA 99, 856–861 (2002).

    CAS  PubMed  PubMed Central  Google Scholar 

  100. Arking, D. E., Atzmon, G., Arking, A., Barzilai, N. & Dietz, H. C. Association between a functional variant of the KLOTHO gene and high-density lipoprotein cholesterol, blood pressure, stroke, and longevity. Circ. Res. 96, 412–418 (2005).

    CAS  PubMed  Google Scholar 

  101. Arantes-Oliveira, N., Apfeld, J., Dillin, A. & Kenyon, C. Regulation of life-span by germ-line stem cells in Caenorhabditis elegans. Science 295, 502–505 (2002).

    CAS  PubMed  Google Scholar 

  102. Gerisch, B., Weitzel, C., Kober-Eisermann, C., Rottiers, V. & Antebi, A. A hormonal signaling pathway influencing C. elegans metabolism, reproductive development, and life span. Dev. Cell 1, 841–851 (2001).

    CAS  PubMed  Google Scholar 

  103. Gerisch, B. & Antebi, A. Hormonal signals produced by DAF-9/cytochrome P450 regulate C. elegans dauer diapause in response to environmental cues. Development 131, 1765–1776 (2004).

    CAS  PubMed  Google Scholar 

  104. Jia, K., Albert, P. S. & Riddle, D. L. DAF-9, a cytochrome P450 regulating C. elegans larval development and adult longevity. Development 129, 221–231 (2002).

    CAS  PubMed  Google Scholar 

  105. Rottiers, V. et al. Hormonal control of C. elegans dauer formation and life span by a Rieske-like oxygenase. Dev. Cell 10, 473–482 (2006).

    CAS  PubMed  Google Scholar 

  106. Held, J. M. et al. DAF-12-dependent rescue of dauer formation in Caenorhabditis elegans by (25S)-cholestenoic acid. Aging Cell 5, 283–291 (2006).

    CAS  PubMed  Google Scholar 

  107. Motola, D. L. et al. Identification of ligands for DAF-12 that govern dauer formation and reproduction in C. elegans. Cell 124, 1209–1223 (2006). Demonstrates a role for a bile-acid-like steroid in the regulation of C. elegans lifespan.

    CAS  PubMed  Google Scholar 

  108. Gerisch, B. et al. A bile acid-like steroid modulates Caenorhabditis elegans lifespan through nuclear receptor signaling. Proc. Natl Acad. Sci. USA 104, 5014–5019 (2007).

    CAS  PubMed  PubMed Central  Google Scholar 

  109. Fisher, A. L. & Lithgow, G. J. The nuclear hormone receptor DAF-12 has opposing effects on Caenorhabditis elegans lifespan and regulates genes repressed in multiple long-lived worms. Aging Cell 5, 127–138 (2006).

    CAS  PubMed  Google Scholar 

  110. Gems, D. et al. Two pleiotropic classes of daf-2 mutation affect larval arrest, adult behavior, reproduction and longevity in Caenorhabditis elegans. Genetics 150, 129–155 (1998). Links insulin/IGF1 signalling and lipophilic signalling to the control of D. melanogaster lifespan.

    CAS  PubMed  PubMed Central  Google Scholar 

  111. Tu, M. P., Yin, C. M. & Tatar, M. Mutations in insulin signaling pathway alter juvenile hormone synthesis in Drosophila melanogaster. Gen. Comp. Endocrinol. 142, 347–356 (2005).

    CAS  PubMed  Google Scholar 

  112. Flatt, T., Tu, M. P. & Tatar, M. Hormonal pleiotropy and the juvenile hormone regulation of Drosophila development and life history. Bioessays 27, 999–1010 (2005).

    CAS  PubMed  Google Scholar 

  113. Tu, M. P., Yin, C. M. & Tatar, M. Impaired ovarian ecdysone synthesis of Drosophila melanogaster insulin receptor mutants. Aging Cell 1, 158–160 (2002).

    CAS  PubMed  Google Scholar 

  114. Jones, G. & Sharp, P. A. Ultraspiracle: an invertebrate nuclear receptor for juvenile hormones. Proc. Natl Acad. Sci. USA 94, 13499–13503 (1997).

    CAS  PubMed  PubMed Central  Google Scholar 

  115. Yao, T. P. et al. Functional ecdysone receptor is the product of EcR and Ultraspiracle genes. Nature 366, 476–479 (1993).

    CAS  PubMed  Google Scholar 

  116. Richard, D. S. et al. Insulin signaling is necessary for vitellogenesis in Drosophila melanogaster independent of the roles of juvenile hormone and ecdysteroids: female sterility of the chico1 insulin signaling mutation is autonomous to the ovary. J. Insect Physiol. 51, 455–464 (2005).

    CAS  PubMed  Google Scholar 

  117. Kliewer, S. A. et al. An orphan nuclear receptor activated by pregnanes defines a novel steroid signaling pathway. Cell 92, 73–82 (1998).

    CAS  PubMed  Google Scholar 

  118. Kodama, S., Koike, C., Negishi, M. & Yamamoto, Y. Nuclear receptors CAR and PXR cross talk with FOXO1 to regulate genes that encode drug-metabolizing and gluconeogenic enzymes. Mol. Cell. Biol. 24, 7931–7940 (2004).

    CAS  PubMed  PubMed Central  Google Scholar 

  119. Schumacher, M. et al. Steroid hormones and neurosteroids in normal and pathological aging of the nervous system. Prog. Neurobiol. 71, 3–29 (2003).

    CAS  PubMed  Google Scholar 

  120. Wredenberg, A. et al. Respiratory chain dysfunction in skeletal muscle does not cause insulin resistance. Biochem. Biophys. Res. Commun. 350, 202–207 (2006).

    CAS  PubMed  Google Scholar 

  121. Cargill, S. L., Carey, J. R., Muller, H. G. & Anderson, G. Age of ovary determines remaining life expectancy in old ovariectomized mice. Aging Cell 2, 185–190 (2003).

    CAS  PubMed  Google Scholar 

  122. Schuur, E. R. et al. Ligand-dependent interaction of estrogen receptor-α with members of the forkhead transcription factor family. J. Biol. Chem. 276, 33554–33560 (2001).

    CAS  PubMed  Google Scholar 

  123. Manson, J. E. et al. Estrogen plus progestin and the risk of coronary heart disease. N. Engl. J. Med. 349, 523–534 (2003).

    CAS  PubMed  Google Scholar 

  124. Pierce, S. B. et al. Regulation of DAF-2 receptor signaling by human insulin and ins-1, a member of the unusually large and diverse C. elegans insulin gene family. Genes Dev. 15, 672–686 (2001).

    CAS  PubMed  PubMed Central  Google Scholar 

  125. Tu, M. P., Epstein, D. & Tatar, M. The demography of slow aging in male and female Drosophila mutant for the insulin-receptor substrate homologue chico. Aging Cell 1, 75–80 (2002).

    CAS  PubMed  Google Scholar 

  126. Bohni, R. et al. Autonomous control of cell and organ size by CHICO, a Drosophila homolog of vertegrate IRS1–4. Cell 97, 865–875 (1999).

    CAS  PubMed  Google Scholar 

  127. Morris, J. Z., Tissenbaum, H. A. & Ruvkun, G. A phosphatidylinositol-3-OH kinase family member regulating longevity and diapause in Caenorhabditis elegans. Nature 382, 536–539 (1996).

    CAS  PubMed  Google Scholar 

  128. Riddle, D. L., Swanson, M. M. & Albert, P. S. Interacting genes in nematode dauer larva formation. Nature 290, 668–671 (1981).

    CAS  PubMed  Google Scholar 

  129. Klass, M. & Hirsh, D. Non-ageing developmental variant of Caenorhabditis elegans. Nature 260, 523–525 (1976).

    CAS  PubMed  Google Scholar 

  130. Dillin, A., Crawford, D. K. & Kenyon, C. Timing requirements for insulin/IGF-1 signaling in C. elegans. Science 298, 830–834 (2002).

    CAS  PubMed  Google Scholar 

  131. Taguchi, A., Wartschow, L. M. & White, M. F. Brain IRS2 signalling coordinates life span and nutrient homeostasis. Science 317, 369–372 (2007).

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Related links

Related links

DATABASES

OMIM

type-1 diabetes

FURTHER INFORMATION

C. Ronald Kahn's homepage

Glossary

Dauer

A long-lived alternative larval stage in worms that is stress and starvation resistant.

Fat body

A fat storage depot in flies that is divided into the cerebral and peripheral fat bodies. FOXO activation in the fat body is sufficient to prolong lifespan.

Diabetic ketoacidosis

Metabolic derangement in the absence of adequate insulin signalling, characterized by marked hyperglycaemia and the excess production of organic acids that are derived from lipolysis.

Insulin resistance

A state characterized by a requirement for elevated levels of insulin to maintain normoglycaemia. Insulin resistance is the earliest defect in the progressive pathogenesis of type-2 diabetes mellitus and is present in individuals who are obese or who have the metabolic syndrome.

Leptin

A peptide hormone produced by adipocytes that negatively regulates food intake and positively regulates metabolic rate. Both leptin deficiency and leptin resistance are associated with obesity. Leptin levels are low in mammals on caloric restriction.

Adiponectin

A peptide hormone that is produced by adipocytes in an amount that is inversely proportional to fat mass. Increased adiponectin levels are associated with increased insulin sensitivity.

Protein deacetylase

An enzyme that removes acetyl groups from N-acetyl-lysine residues in proteins. Some of the sirtuins, including SIRT1, have deacetylase activity.

Resveratrol

A plant terpenoid compound that can activate the deacetylase activity of SIRT1 and orthologous sirtuins.

Glycosidase family-1 enzyme

One of a related family of enzymes that hydrolyze glycosidic bonds between monosaccharide components of polysaccharides.

Steroid glucuronide

A steroid modified by the covalent addition of glucuronic acid via a glycosidic bond, with the usual effect of increasing water solubility and decreasing biological activity.

Corpora allata

A neuroendocrine organ that is attached to the brain of flies and produces juvenile hormone and ecdysone in response to insulin/IGF1-like signalling.

Diapause

A state of decreased metabolic activity during which reproduction is suspended to await improved conditions.

Pregnane

A steroid with 21 carbons. Examples include pregnenolone or progesterone.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Russell, S., Kahn, C. Endocrine regulation of ageing. Nat Rev Mol Cell Biol 8, 681–691 (2007). https://doi.org/10.1038/nrm2234

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrm2234

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing